Cargando…
Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
Etoposide is commonly used in a variety of malignancies. A well known but rare toxicity are hypersensitivity reactions, usually manifested by chest discomfort, dyspnoea, bronchospasm and hypotension. We report the details of a patient who developed hypersensitivity reactions to intravenous etoposide...
Autores principales: | Siderov, J, Prasad, P, De Boer, R, Desai, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746527/ https://www.ncbi.nlm.nih.gov/pubmed/11857004 http://dx.doi.org/10.1038/sj.bjc.6600003 |
Ejemplares similares
-
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997) -
Severe hypersensitivity reaction to etoposide phosphate: A case report
por: Cotteret, Camille, et al.
Publicado: (2020) -
Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997) -
Hypersensitivity to Etoposide in Case of Metastatic Gestational Choriocarcinoma
por: Lazović, Biljana, et al.
Publicado: (2013) -
Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer
por: Levitt, N C, et al.
Publicado: (2005)